Navigation Links
News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes
Date:6/29/2009

Scientists at the National Institute on Drug Abuse (VIDA) working in collaboration with colleagues at Vector Tobacco, Inc. and Duke University Medical School have identified genes that may help predict which people will have a better chance at kicking the tobacco habit.

Manhasset, NY (Vocus) June 29, 2009 -- Scientists at the National Institute on Drug Abuse (VIDA) working in collaboration with colleagues at Vector Tobacco, Inc. and Duke University Medical School have identified genes that may help predict which people will have a better chance at kicking the tobacco habit. NIDA's Tomas Drgon, PhD, and colleagues conducted a genome-wide association study that identified patterns that may determine quitting success rates. If replicated, genetic testing could be used to tailor smoking cessation programs to individuals.

In another study, a team of Swedish investigators examined insulin signaling in fat cells of lean individuals before, during and after a month-long high fat diet. During the study, the volunteers gained an average of 10 percent of their body weight and 19 percent total body fat. While they remained lean, they did develop moderate systemic insulin resistance. Insulin resistance has become an enormous public health problem that paves the way to type 2 diabetes and other medical conditions. It is the first study to measure the effects of a short-term high fat diet, and it shows that the assault of such a diet is already causing damage to the body's ability to regulate insulin. This study suggests a path for how diabetes may develop in otherwise healthy individuals and provides further evidence that a high-calorie, high-fat diet is a significant risk factor for type 2 diabetes.

Also, in a possible future breakthrough for personalized medicine, Dr. H. Shaw Warren of Massachusetts General Hospital and colleagues from research centers nationwide took advantage of genomic screening methods to assess gene expression from trauma patient blood samples. They developed a scoring method that assigns a single value based on genome wide expression patterns termed the difference from reference score, or DFR. The authors found that DFR scoring improves upon existing methodologies for predicting outcomes in trauma patients. High throughput approaches such as DFR scoring could improve the quality and efficacy of trauma patient care.

You can view all of the articles in the July-August issue by visiting the journal's Web site at www.molmed.org.

Molecular Medicine is published by The Feinstein Institute for Molecular Research. The peer-reviewed journal strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. The journal, a bimonthly publication, serves as a forum through which scientists and researchers can communicate recent discoveries to a multi-disciplinary, international audience interested in understanding and curing disease.

To listen to the latest podcast on these studies visit www.molmed.org/podcast.html.

Veronica J Davis, communications editor, 516-562-2670

###

Read the full story at http://www.prweb.com/releases/smoking/insulin/prweb2584204.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
2. Scientists, physicians present latest findings in personalized cancer treatment and prevention
3. Medicare Prescription Drug Benefit, Nonprofit Hospitals, Ambulatory Surgery Centers, Statistical Methods, and Pay-For-Performance Highlighted In the Latest INQUIRY Journal
4. Health psychologists discuss latest research findings
5. AIDS Action Council Praises Release of Latest State of AIDS in Black America Report
6. PA Governor Rendell Announces Latest Nominations and Appointments
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Big Tobaccos Latest Dirty Trick: Deceiving Oregon Voters
9. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
10. The latest about male infertility and testosterone from NewYork-Presbyterian/Weill Cornell
11. Cejka Search Experts Present Latest Developments in Physician and Healthcare Employment at Leading Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
News from the Latest Issue of Molecular Medicine Kicking The Habit - It's In The Genes
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology: